Shield Therapeutics PLC (STX)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
11.50p
Buy
12.00p
0.55p (+4.91%)
Prices updated at 17 Dec 2025, 15:59 GMT
| Prices minimum 15 mins delay
Prices in GBX
Shield Therapeutics PLC is focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals. It is a specialty pharmaceutical company.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 13m | 32m | |
| 4m | 15m | |
| -31m | -23m | |
| -239.44 | -71.08 | |
| -33m | -27m | |
| -30m | -21m | |
| Sales, General and administrative | 37m | 35m |
| Interest expenses | 1m | 4m |
| Provision for income taxes | 918,000 | 626,000 |
| Operating expenses | 35m | 38m |
| Income before taxes | -32m | -27m |
| Net income available to common shareholders | -33m | -27m |
| -0.05 | -0.03 | |
| Net interest income | -501,000 | -4m |
| Advertising and promotion | - | - |
| Net investment income, net | -543,000 | -76,000 |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -0.05 | -0.03 |
| Free cash flow per share | -0.0476 | -0.0242 |
| Book value/share | 0.0272 | 0.0004 |
| Debt equity ratio | 1.332469 | - |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 31m | 38m |
| Current liabilities | 14m | 33m |
| Total capital | 35m | 25m |
| Total debt | 20m | 26m |
| Total equity | 15m | -1m |
| Total non current liabilities | - | - |
| Loans | 20m | 26m |
| Total assets | 49m | 57m |
| Total liabilities | - | - |
| Cash and cash equivalents | 14m | 7m |
| Common stock | 782m | 1,042m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 3m | 14m |
| Cash dividends paid | - | - |
| -40m | -9m | |
| Investments (gains) losses | -2m | -2m |
| 14m | 7m | |
| Net income | - | - |
| -37m | -7m | |
| -3m | -2m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
